SCHEMBL26435249

SCHEMBL26435249

c1ccc2c(c1)ccc1cccc(-c3nc(-c4ccc5oc6ccccc6c5c4)nc(-c4cc5cccnc5c5ncccc45)n3)c12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.38
KDM4E B2RXH2 5/20 0.38
ALDH1A1 P00352 5/20 0.38
HPGD P15428 3/20 0.38
HSD17B10 Q99714 3/20 0.38
GAA P10253 1/20 0.38
NPC1 O15118 2/20 0.36
AHR P35869 2/20 0.35
PDE4D Q08499 2/20 0.35
CCR1 P32246 2/20 0.35
CCR8 P51685 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
GRM4 Q14833 1/20 0.35
ABCG2 Q9UNQ0 3/20 0.34
ALOX5 P09917 1/20 0.33
CHEK2 O96017 1/20 0.33
MEN1 O00255 1/20 0.33
ESR1 P03372 1/20 0.33
POLB P06746 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26435100 0.88 ALDH1A1 (0.40) MAPTKDM4EALDH1A1HPGDHSD17B10
SCHEMBL26435590 0.87 ALOX5 (0.38) MAPTKDM4EALDH1A1HPGDHSD17B10
SCHEMBL26435745 0.87 ALDH1A1 (0.34) MAPTKDM4EALDH1A1HPGDHSD17B10
SCHEMBL26435220 0.85 ABCG2 (0.40) MAPTKDM4EALDH1A1HPGDHSD17B10
SCHEMBL26434972 0.85 ALOX5 (0.45) MAPTKDM4EALDH1A1HPGDHSD17B10
SCHEMBL20726665 0.85 MAPT (0.40) MAPTKDM4EALDH1A1HPGDHSD17B10
SCHEMBL26435218 0.84 ABCG2 (0.42) MAPTKDM4EALDH1A1HPGDHSD17B10
SCHEMBL20726663 0.84 MAPT (0.42) MAPTKDM4EALDH1A1HPGDHSD17B10
SCHEMBL26435221 0.83 ABCG2 (0.41) MAPTKDM4EALDH1A1HPGDHSD17B10
SCHEMBL26435234 0.83 ABCG2 (0.41) MAPTKDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS NOM1, MNS1, NOS1 MAPT 2425/4885KDM4E 1841/4885ALDH1A1 1532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.